Lanëelle M A, Silve G, López Marín L M, Daffé M
Laboratoire de Pharmacologie et de Toxicologie Fondamentales du Centre National de la Recherche Scientifique, Toulouse, France.
Eur J Biochem. 1996 May 15;238(1):270-9. doi: 10.1111/j.1432-1033.1996.0270q.x.
Among the fast-growing mycobacteria, members of the Mycobacterium fortuitum complex are the most-commonly cited opportunistic human pathogens, notably in post-surgical infections. Previous studies showed that this complex was composed of four well-identified species and a group of isolates that did not correspond to recognized species, which has been referred to as the third biovariant complex. The occurrence and chemical structure of the glycolipid antigens of six strains that belong to this latter group were examined in the present study. Based on the TLC profiles, resistance to alkali and seroreactivities of their glycolipids, the examined strains were classified into three groups: one group was devoid of species-specific glycolipid and the two other groups contained alkali-stable or alkali-labile glycoconjugates. The structures of the major glycolipid antigens of the latter two groups were elucidated by fast-atom-bombardment MS, one-dimensional and two-dimensional NMR spectroscopy and conventional chemical analyses. The alkali-stable glycolipids were structurally identical to the C-mycoside-type glycopeptidolipids characterized in the taxonomically related species Mycobacterium peregrinum. The major alkali-labile glycolipid was identified as beta-Glcp-1 --> 6)-alpha-Glcp2Acyl-(1 --> 1)-alpha-GLcp3,4,6Acyl3. The acyl substituents consisted on one acetyl group and three fatty acyl residues composed mainly of tetradecanoyl residues, but significant amounts of 2-methylhexadecanoyl and 2-methyloctadecanoyl substituents were also present. The heterogeneity of the glycolipid content of members of the third biovariant complex of M. fortuitum demonstrated in the present study confirms the heterogeneity of the complex. In addition, the occurrence of a species-specific glycolipid in some strains supports the hypothesis that some strains of this complex of M. fortuitum may belong to a new mycobacterial species.
在快速生长的分枝杆菌中,偶然分枝杆菌复合体的成员是最常被提及的人类机会性病原体,尤其是在外科手术后感染中。先前的研究表明,该复合体由四个已明确鉴定的物种和一组不符合公认物种的分离株组成,后者被称为第三生物变种复合体。本研究检测了属于后一组的六个菌株的糖脂抗原的发生情况和化学结构。根据薄层层析图谱、其糖脂对碱的抗性和血清反应性,将检测的菌株分为三组:一组没有物种特异性糖脂,另外两组含有碱稳定或碱不稳定的糖缀合物。通过快原子轰击质谱、一维和二维核磁共振光谱以及传统化学分析阐明了后两组主要糖脂抗原的结构。碱稳定的糖脂在结构上与分类学上相关的物种——龟分枝杆菌中鉴定的C-霉菌糖苷型糖肽脂相同。主要的碱不稳定糖脂被鉴定为β-Glcp-(1→6)-α-Glcp2Acyl-(1→1)-α-GLcp3,4,6Acyl3。酰基取代基由一个乙酰基和三个主要由十四烷酰基残基组成的脂肪酰基残基组成,但也存在大量的2-甲基十六烷酰基和2-甲基十八烷酰基取代基。本研究中证明的偶然分枝杆菌第三生物变种复合体成员糖脂含量的异质性证实了该复合体的异质性。此外,一些菌株中存在物种特异性糖脂支持了这样一种假设,即偶然分枝杆菌复合体的一些菌株可能属于一个新的分枝杆菌物种。